Aplastic Anemia & MDS International Foundation, Inc.
Text Size     | Printer-friendly page

Blood Transfusions


  Return to Q&A Library

  Filtered and Irradiated Blood
  Irradiation of Transfused Blood
  Transfusion Dependent & Complications
  Developing Antibodies after Transfusions
  Acceptable Platelet Counts
  Religious Objection to Blood Transfusion
  ATG Without Blood Transfusion?


Filtered and Irradiated Blood

Why is it important for aplastic anemia, MDS, and PNH patients to requests filtered and irradiated blood when receiving transfusions?

Screening out damaging leukocytes with leukocyte blood filters is essential to minimized adverse reactions following blood transfusions. Low-level radiation also reduces the amount of lymphocytes in blood, reducing the risk of transfusion-associated graft-versus-host disease. For optimum results, both processes should have been carried out on the blood for your transfusion, but you will need to check this at the time of ordering, and ask the nurse to check again at the bedside. In addition, try for blood that has been leukocyte-filtered before storage, rather than filtered at the bedside. The former is more efficiently filtered. There are no known negative side-effects to blood treated in these ways. A spokesperson at America's Blood Centers stated that insurance companies generally accept the need for these products when fighting aplastic anemia and MDS.


Irradiation of Transfused Blood

Does irradiation eliminate the formation of antibodies when you receive red blood cells?

No,

Application of radiation for therapeutic purposes.
irradiation does not eliminated the formation of
A protein produced by the immune system in response to the presence of an antigen (foreign substance).
antibodies
against
The oxygen carrying cells in our body. These bring oxygen to our tissues, and are the most numerous of the blood cells.
red blood cells
or
An important part of our body’s defense against infection and clearing the body of harmful toxins - our immune system.
white blood cells
; it only prevents the blood donor's white blood cells from being able to multiply in the recipients blood and mount an immune response against the recipient.
In order to prevent formation of antibodies, which may eventually limit the response to transfused
The smallest cells in the blood, essential for blood clotting. Also, called thrombocytes.
platelets
, red cells and platelets should also be filtered, which removes white cells. This may also prevent immediate infusion reactions and decrease the chance of the recipient acquiring
A widespread opportunistic virus that can cause disease in an immunosuppressed person.
Cytomegalovirus
(CMV), which is a widespread opportunistic virus that can cause disease in an immune suppressed person.


Transfusion Dependent & Complications

How long can a person have blood transfusions? What are the complications?

There is no limit to the time in which a patient can receive blood transfusions, even up to 20 years. However there are some complications which can arise.

The oxygen carrying cells in our body. These bring oxygen to our tissues, and are the most numerous of the blood cells.
Red blood cells transfusions contain iron that accumulates in the body and can damage normal tissues. The immune system is stimulated by exposure to proteins on the transfused blood cells and over time, the patient may produce
A protein produced by the immune system in response to the presence of an antigen (foreign substance).
antibodies
that destroy the transfused red blood cells or platelets. Blood transfusions may contain viruses or other infections that may be passed to the recipient. However, the blood supply is safer now than ever due to development of test to detect the major infections which can be passed by transfusion, but there remains a risk of transfusion related infection.


Developing Antibodies after Transfusions

Are there any statistics on the development of antibodies by transfusion recipients? Are there an average number of units before the risk climbs to significant levels?

Some patients develop

A protein produced by the immune system in response to the presence of an antigen (foreign substance).
antibodies after only one transfusion while others never develop antibodies. 
The oxygen carrying cells in our body. These bring oxygen to our tissues, and are the most numerous of the blood cells.
Red blood cells
antibodies occur in patients with rare blood types. These patients lack
Protein present on the surface of cells that can stimulate an immune reaction.
antigens
, or markers, on the red blood cell surface.   White cell antibodies can occur because of differences in the HLA types between donors and recipients. This can cause problems for patients who need platelet transfusions, because the platelets carry the same HLA antigens.   A conservative approach is to use transfusions only when they are necessary.


Acceptable Platelet Counts

What is an acceptable platelet count for patients who are not having symptoms?

The numbers are not as important as the symptoms. If a patient is treated in a supportive fashion, most patients can tolerate extremely low

The smallest cells in the blood, essential for blood clotting.
platelet counts as long as they are not bleeding. If bleeding occurs, Amicar can be tried. For patients who have had a major bleeding complication, the physician would tend to be more aggressive and transfuse when the platelet counts go below 10,000 even if there is not active bleeding at that point.


Religious Objection to Blood Transfusion

What other treatments are available for Jehovah's Witness patients who have a religious objection the use of blood transfusion?

Cyclosporine (Neoral, Sandimmune) is an immunosuppressant, a drug that reduces the body's natural immunity. Cyclosporine is used along with anti-thymocyte globulin (ATG), another immunosuppressant, for treating aplastic anemia.
Cyclosporine does not carry the risk of transiently causing low
The smallest cells in the blood, essential for blood clotting. Also, called thrombocytes.
platelets
(such as in anti-thymocyte globulin,
ATG (Atgam, Thymoglobulin) is an immunosuppressant, a drug therapy that reduces the body's natural immunity. It is approved by U.S. Food and Drug Administration (FDA) for treating moderate to severe aplastic anemia patients. ATG is most commonly used with cyclosporine, an oral medicine. ATG/cyclosporine combination is sometimes used for treating myelodysplastic syndromes (MDS), but is not nearly as effective against MDS as it is aplastic anemia.
ATG
) and could be tried. A few patients have been treated with colony-stimulating factors, such as
Epoetin alfa (Epogen, Procrit) promotes red blood cell production in the bone marrow and is known as a growth factor. Growth factors are normal chemicals in the body that encourage the bone marrow to make blood cells. Growth factors have been manufactured as drugs to stimulate the bone marrow to produce more blood cells.
erythropoietin
(Procrit, Epogen) or granulocyte colony stimulating factors (G-CSF, Filgrastim). These may increase the white counts and
The most numerous of the white blood cells, important for helping the body fight infections (particularly bacterial and fungal infections; see also bands, PMNs, polys, stabs, and segs).
neutrophils
but would not be expected to cure the patient or to change the risk of dying from severe complication.


ATG Without Blood Transfusion?

What are the success rates of ATG therapy without blood transfusion support for aplastic anemia patients?

At the moment there is no substitute for the transfusion of blood and of certain blood products. With respect to the use of these agents in the course of

ATG (Atgam, Thymoglobulin) is an immunosuppressant, a drug therapy that reduces the body's natural immunity. It is approved by U.S. Food and Drug Administration (FDA) for treating moderate to severe aplastic anemia patients. ATG is most commonly used with cyclosporine, an oral medicine. ATG/cyclosporine combination is sometimes used for treating myelodysplastic syndromes (MDS), but is not nearly as effective against MDS as it is aplastic anemia.
ATG (anti-thymocyte globulin) treatment, it will depend to some extent on the blood count before starting ATG.
A decrease in the number of platelets in the blood, resulting in the potential for increased bleeding and decreased ability for clotting.
Thrombocytopenia
is a serious problem which may be made transiently worse during a course of ATG: therefore
The smallest cells in the blood, essential for blood clotting.
platelet
transfusions are given almost in every case to patients with aplastic anemia or PNH who receive ATG treatment.


Join Us | Make A Donation | Site Map | Glossary | Legal & Privacy Notices
AA&MDSIF, PO Box 310, Churchton, MD 20733 U.S.A. help@aamds.org